About the ICR
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years.
We are world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy. As well as being a world-class research institute, the ICR is a higher education institution and a member institution of the University of London. We came second-top in the league table of university research quality, impact and environment compiled from the most recent Research Excellence Framework (REF 2021).
The ICR is led by Chief Executive Professor Kristian Helin, known for his pioneering scientific discoveries in cancer epigenetics.
The ICR has charitable status and relies on support from partner organisations, charities, donors and the general public.
For 100 years and counting, we've been making cancer discoveries.
We discover more cancer drugs than any other academic centre in the world.
96 per cent of our expenditure is on research and research support.
The ICR and The Royal Marsden
We work in close partnership with The Royal Marsden NHS Foundation Trust to take the results of our research rapidly into the clinic, with the aim of developing better treatments for cancer patients.
Together, we are rated as one of the top centres for cancer research and treatment worldwide.
Our strategy
Our vision: We will transform the lives of cancer patients through world-class research and education, and by growing our impact on society.
Our values
Our values shape how we work at the ICR, from our commitment to equality and inclusion to our responsibility to act sustainably.
Our policy and engagement work
By engaging with parliamentarians and policymakers, we advocate for policy outcomes which make it easier for our researchers to do their vital work. We also support staff to engage meaningfully with the public by offering them training, one-to-one advice and written guidance.
How we are structured
The Institute of Cancer Research, London, operates as a research institute, a higher education institution and an exempt charity. Its structure and governance arrangements reflect these multiple organisational roles.